AFPT – Le Club Phase 1 Newsletter #5
Click here : AFPT Newsletter 5_230127
This author has not written his bio yet.
But we are proud to say that HENRI CAPLAIN contributed 27 entries already.
Click here : AFPT Newsletter 5_230127
If your are interesting to sponsor or to have an exhibition at the next EUFEMED conference in BErlin, please click on the following link : https://ogy.de/EUFEMED-Partnership
If you are interested to submit an abstract, please click on the following link: https://eufemed-conference.eu/2023/wp-content/uploads/Abstract_submision_template_EUFEMED2023.pdf
Programme AFPT_Juin 2022_Final_V5_HC Please click on the following links to see the available presentations (authorised by the Authors): 1_1_Breathing New Life into FTiH Dose Predictions – Inhaled PBPK Modelling – Simon Teague Le Club Phase1 June 2022 1_2_AFPT2022_Balazki 1_3_AFPT_KLH model_JUN2022_extract 1_4_FINAL_AFPT_June 2022_DILIsym CGRP Rc antagonists 2_1_Massard BASKET P1 AFPT2022vfinal 2_2_AFPT_ master protocol _16June2022_MH 2_3_French Club […]
7 October 2022 – ONLINE
02 March 2022, 17:00 – 02 March 2022, 18:30 (UTC+01:00) Bruxelles, Copenhague, Madrid, Paris REGISTRATION LINK (MANDATORY): https://teams.microsoft.com/registration/tgoS-U_pR0GIPMJJajtO5Q,iiwcKel7s0Wn59cprzvTGg,yx6hQ9XN9Eq3n0HmXyIXWQ,ED2KZGrLSEeMoEMg0wARoA,Qtdma1XV_UyYXI6cScx66A,jxHTtmIYkkKap-g2HEEe6Q?mode=read&tenantId=f9120ab6-e94f-4147-883c-c2496a3b4ee5
Programme AFPT_Juin 2022_Final_V2_HC
Job offer: Crossject – CDI Chef(fe) de projet étude clinique Click on the following link for the job description: CDI Chef de projet étude clinique
Job offer: Medical Director – Clinical Pharmacology (Neuroscience) | Novartis
Conference_Eufemed_2021 Programme click on: https://www.eufemed-conference.eu/2021/programme/
French association of the professionals of human and translational pharmacology
34, avenue des Champs-Elysées 75008 Paris 8ème, France
A founding member of
EUROPEAN FEDERATION FOR EXPLORATORY MEDICINES DEVELOPMENT
june
19jun15 h 00 min16 h 00 minOnline Webinar: First-In-Human Dose Selection & Approaches
more
To start the clinical development, the first-in-human dose selection including the starting dose and the dose range is a key step for a successful clinical drug development with small molecules or biologics. There is no unique approach.
Save the date: June 19th (3:00-4:00 pm CET/ 9:00-10:00 am EDT) to review the different approaches with a subject matter expert.
A separate webinar on September 23rd, 2024 will focus especially on the dose optimization in oncology.
(Wednesday) 15 h 00 min - 16 h 00 min ECT
ONLINE
AFPT - Le Club Phase 1